[1] Travis WD, Brambilla E, Burke AP, et al. WHO classification of tumours of lung, pleura, thymus and heart[M]. 4th ed. Lyon:IARC Press, 2015. [2] Travis W D, Brambilla E, Muller-Hermelink H K, et al. World Health Organisation Classification of tumours. Pathology and genetics: tumours of the lung, pleura, thymus and heart [M]. Lyon: IARC Press,2004:9-87. [3] Travis W D, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma [J]. J Thorac Oncol, 2011,6(2):244-85. [4] Travis WD, Colby TV, Corrin B, et al. World Health Organization International Histological Classification of Tumours: Histological Typing of Lung and Plueral Tumours (ed 3) [M]. Berlin, Germany, Springer, 1999. [5] Kadota K, Villena-Vargas J,Yoshizawa A, et al. Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage Ⅰ disease [J]. Am J Surg Pathol,2014,38(4):448-460.
|